Loading...
LivaNova PLC
LIVN•NASDAQ
Healthcare
Medical - Devices
$43.67
$0.38(0.88%)
LivaNova PLC (LIVN) Financial Performance & Income Statement Overview
Review LivaNova PLC’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.66%
↑ 8.66%
Operating Income Growth
288.40%
↑ 288.40%
Net Income Growth
260.39%
↑ 260.39%
Operating Cash Flow Growth
144.33%
↑ 144.33%
Operating Margin
13.15%
↑ 13.15%
Gross Margin
69.45%
↑ 69.45%
Net Profit Margin
-17.42%
↓ 17.42%
ROE
-18.11%
↓ 18.11%
ROIC
9.23%
↑ 9.23%
LivaNova PLC (LIVN) Income Statement & Financial Overview
Review LivaNova PLC's (LIVN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $321.80M | $318.12M | $318.57M | $294.91M |
| Cost of Revenue | $102.48M | $92.86M | $98.21M | $84.32M |
| Gross Profit | $219.32M | $225.26M | $220.37M | $210.59M |
| Gross Profit Ratio | $0.68 | $0.71 | $0.69 | $0.71 |
| R&D Expenses | $43.31M | $48.80M | $44.74M | $41.86M |
| SG&A Expenses | $135.62M | $131.66M | $129.12M | $129.86M |
| Operating Expenses | $182.33M | $189.65M | $173.85M | $171.73M |
| Total Costs & Expenses | $281.30M | $282.50M | $272.06M | $256.05M |
| Interest Income | $8.58M | $7.14M | $7.34M | $7.02M |
| Interest Expense | $15.77M | $15.88M | $15.53M | $15.89M |
| Depreciation & Amortization | $12.58M | $13.13M | $12.29M | $13.14M |
| EBITDA | $84.88M | $73.45M | $49.41M | -$5.17M |
| EBITDA Ratio | $0.26 | $0.23 | $0.16 | -$0.02 |
| Operating Income | $37.02M | $35.62M | $46.51M | $38.86M |
| Operating Income Ratio | $0.12 | $0.11 | $0.15 | $0.13 |
| Other Income/Expenses (Net) | $19.48M | $8.82M | -$18.58M | -$50.45M |
| Income Before Tax | $56.50M | $44.44M | $21.59M | -$34.20M |
| Income Before Tax Ratio | $0.18 | $0.14 | $0.07 | -$0.12 |
| Income Tax Expense | $600000.00 | $11.53M | $5.23M | $7.72M |
| Net Income | $55.89M | $32.95M | $16.33M | -$41.94M |
| Net Income Ratio | $0.17 | $0.10 | $0.05 | -$0.14 |
| EPS | $1.03 | $0.61 | $0.30 | -$0.78 |
| Diluted EPS | $1.02 | $0.60 | $0.30 | -$0.78 |
| Weighted Avg Shares Outstanding | $54.40M | $54.35M | $54.24M | $54.008M |
| Weighted Avg Shares Outstanding (Diluted) | $54.70M | $54.59M | $54.59M | $54.008M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan